Clinical implications
embolism, device-detected, stroke
EMBOLISM, STROKE
The findings of this study highlight the need for strategies to address the ischemic stroke/systemic embolism risk that remains unaddressed in a significant proportion of patients with device-detected AF. Education regarding stroke risk in patients with subclinical AF and the net clinical benefit of anticoagulation in high-risk patients provides one with potential opportunity to manage better this patient cohort. Furthermore, implementation of structured RM clinical response pathways and integrated care, to promote consideration of anticoagulation, is required. Given the burden that AF episodes place on current RM pathways, systems can be re-designed with inclusion of automated features to prompt anticoagulation decisions as an alternative to reliance on human prompts.